Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Efficacy and safety of Vitex agnus-castus extract for treatment of premenstrual syndrome in Japanese patients: a prospective, open-label study.

Momoeda M, Sasaki H, Tagashira E, Ogishima M, Takano Y, Ochiai K.

Adv Ther. 2014 Mar;31(3):362-73. doi: 10.1007/s12325-014-0106-z. Epub 2014 Mar 7.

PMID:
24604699
2.

Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome.

Schellenberg R, Zimmermann C, Drewe J, Hoexter G, Zahner C.

Phytomedicine. 2012 Nov 15;19(14):1325-31. doi: 10.1016/j.phymed.2012.08.006. Epub 2012 Sep 28.

PMID:
23022391
3.

Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS).

Berger D, Schaffner W, Schrader E, Meier B, Brattström A.

Arch Gynecol Obstet. 2000 Nov;264(3):150-3.

PMID:
11129515
4.

Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women.

Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X.

Aust N Z J Obstet Gynaecol. 2010 Apr;50(2):189-93. doi: 10.1111/j.1479-828X.2010.01137.x.

PMID:
20522079
5.

Treatment of moderate to severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women.

Ma L, Lin S, Chen R, Wang X.

Gynecol Endocrinol. 2010 Aug;26(8):612-6. doi: 10.3109/09513591003632126.

PMID:
20334585
6.

Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China.

He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S, Yao Y, Lu J, Lin S.

Maturitas. 2009 May 20;63(1):99-103. doi: 10.1016/j.maturitas.2009.01.006. Epub 2009 Mar 9.

PMID:
19269753
7.

[Vitex Agnus Castus in the treatment of hyperprolactinemia and menstrual disorders - a case report].

Męczekalski B, Czyżyk A.

Pol Merkur Lekarski. 2015 Jul;39(229):43-6. Polish.

PMID:
26277178
8.

Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome.

Zamani M, Neghab N, Torabian S.

Acta Med Iran. 2012;50(2):101-6.

9.

Use of Vitex agnus-castus in migrainous women with premenstrual syndrome: an open-label clinical observation.

Ambrosini A, Di Lorenzo C, Coppola G, Pierelli F.

Acta Neurol Belg. 2013 Mar;113(1):25-9. doi: 10.1007/s13760-012-0111-4. Epub 2012 Jul 12.

PMID:
22791378
11.

Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus.

Loch EG, Selle H, Boblitz N.

J Womens Health Gend Based Med. 2000 Apr;9(3):315-20.

PMID:
10787228
12.

Vitex agnus castus: a systematic review of adverse events.

Daniele C, Thompson Coon J, Pittler MH, Ernst E.

Drug Saf. 2005;28(4):319-32. Review.

PMID:
15783241
13.

The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis.

Verkaik S, Kamperman AM, van Westrhenen R, Schulte PF.

Am J Obstet Gynecol. 2017 Feb 22. pii: S0002-9378(17)30319-8. doi: 10.1016/j.ajog.2017.02.028. [Epub ahead of print] Review.

PMID:
28237870
14.

The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study.

Gerhardsen G, Hansen AV, Killi M, Fornitz GG, Pedersen F, Roos SB.

Adv Ther. 2008 Jun;25(6):595-607. doi: 10.1007/s12325-008-0072-4.

PMID:
18568441
15.

[The premenstrual syndrome: effectiveness of Vitex agnus castus].

Döll M.

Med Monatsschr Pharm. 2009 May;32(5):186-91. Review. German.

PMID:
19469189
16.

[Psychic aspects of the premenstrual dysphoric disorders. New therapeutic strategies: our experience with Vitex agnus castus].

Ciotta L, Pagano I, Stracquadanio M, Di Leo S, Andò A, Formuso C.

Minerva Ginecol. 2011 Jun;63(3):237-45. Italian.

PMID:
21654609
17.

Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.

Atmaca M, Kumru S, Tezcan E.

Hum Psychopharmacol. 2003 Apr;18(3):191-5.

PMID:
12672170
18.

Activation of the mu-opiate receptor by Vitex agnus-castus methanol extracts: implication for its use in PMS.

Webster DE, Lu J, Chen SN, Farnsworth NR, Wang ZJ.

J Ethnopharmacol. 2006 Jun 30;106(2):216-21. Epub 2006 Jan 24.

PMID:
16439081
19.

Pilot study of the efficacy and safety of a modified-release magnesium 250 mg tablet (Sincromag) for the treatment of premenstrual syndrome.

Quaranta S, Buscaglia MA, Meroni MG, Colombo E, Cella S.

Clin Drug Investig. 2007;27(1):51-8.

PMID:
17177579
20.

A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.

Graham CA, Sherwin BB.

J Psychosom Res. 1992 Apr;36(3):257-66.

PMID:
1564678

Supplemental Content

Support Center